Table 2 Isolation proportions of microorganisms and antimicrobial-resistant microorganisms

Staphylococcus aureus

378

14.4%

±7.7%

13.2%

(9.6–17.3%)

15.0%

±7.4%

14.2%

(9.7–19.0%)

0.046

 Methicillin-resistant

378

37.8%

±14.3%

34.9%

(28.6–43.9%)

37.9%

±13.3%

35.8%

(28.6–44.7%)

0.342

  Methicillin-resistant, in a blood sample

378

6.0%

±4.3%

5.1%

(3.2–8.1%)

6.8%

±4.9%

6.2%

(3.9–8.8%)

0.002

Streptococcus pneumoniae

296

2.1%

±2.3%

1.5%

(0.8–2.7%)

1.9%

±2.7%

1.2%

(0.7–2.1%)

<.001

 Penicillin-resistant

296

22.6%

±21.9%

18.9%

(0.3–40.4%)

29.1%

±20.8%

33.3%

(5.5–45.5%)

<.001

Escherichia coli

298

12.8%

±7.3%

11.8%

(8.3–15.7%)

12.6%

±5.9%

11.6%

(9.0–15.4%)

0.181

 Fluoroquinolone-resistant

298

27.2%

±11.0%

27.8%

(19.7–34.4%)

29.4%

±10.6%

30.0%

(22.0–36.4%)

<.001

Pseudomonas aeruginosa

299

4.7%

±3.3%

4.1%

(2.7–5.8%)

5.2%

±2.9%

4.8%

(3.4–6.4%)

<.001

 Carbapenem-resistant

299

10.8%

±7.2%

9.8%

(6.0–14.8%)

10.8%

±7.1%

10.0%

(5.1–15.6%)

0.843

Enterobacteriaceae

279

22.5%

±10.9%

21.2%

(15.2–28.0%)

18.6%

±9.3%

17.2%

(13.2–22.9%)

<.001

 Carbapenem-resistant

279

1.0%

±1.5%

0.5%

(0.1–1.4%)

0.9%

±1.7%

0.2%

(0.0–0.9%)

0.001